According to the Komei Diagnosis announcement, CICC Kangrui Phase I Equity Investment Fund Partnership, a shareholder holding 5% or more of the shares, reduced its holdings of the company's shares by 2.655 million shares through centralized bidding from July 7 to July 15, 2026, accounting for 0.6620% of the total share capital. After this change in equity, the shareholder's shareholding fell to 2.0552 million shares, accounting for 4.9999% of the company's current total share capital, and is no longer a shareholder holding more than 5% of the listed company's shares. Previously, it planned to reduce its holdings by no more than 2.7 million shares. The plan to reduce its holdings has not been completed, and the possibility of continuing to reduce its holdings within the next 12 months is not ruled out.

According to the Komei Diagnosis announcement, CICC Kangrui Phase I Equity Investment Fund Partnership, a shareholder holding 5% or more of the shares, reduced its holdings of the company's shares by 2.655 million shares through centralized bidding from July 7 to July 15, 2026, accounting for 0.6620% of the total share capital. After this change in equity, the shareholder's shareholding fell to 2.0552 million shares, accounting for 4.9999% of the company's current total share capital, and is no longer a shareholder holding more than 5% of the listed company's shares. Previously, it planned to reduce its holdings by no more than 2.7 million shares. The plan to reduce its holdings has not been completed, and the possibility of continuing to reduce its holdings within the next 12 months is not ruled out.